Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Breaking Barriers: Advancements in CNS Drug Delivery for Glioblastoma. | Med Sci (Basel) | 2026 | 41718120 | PubTator, text mining | PubMed |
| Mechanistic basis for the antifibrotic actions of cAMP-based therapies. | Eur Respir Rev | 2026 | 41708123 | PubTator, text mining | PubMed |
| Cell therapy for brain tumors: The first 60 years. | Cell Rep Med | 2026 | 41707655 | PubTator, text mining | PubMed |
| The role of tumor-associated macrophages in cancer development and their significance as prognostic markers. | Clin Exp Med | 2026 | 41697492 | PubTator, text mining | PubMed |
| The safety and efficacy of bispecific T-cell engagers (TCEs) in patients with glioma. | Clin Exp Med | 2026 | 41689667 | PubTator, text mining | PubMed |
| CAR-T cell therapies are coming after glioblastoma: An overview of early phase clinical trials and future perspectives. | iScience | 2026 | 41675045 | PubTator, text mining | PubMed |
| LEF1 and IL13RA2 in testicular sex cord-stromal tumors: LEF1 as a potential diagnostic marker for Sertoli cell tumors. | Ann Diagn Pathol | 2026 | 41671911 | PubTator, text mining | PubMed |
| Multiomics-driven discovery of predictive biomarkers and strategies to overcome resistance to SFK-YAP inhibition in cholangiocarcinoma. | bioRxiv | 2026 | 41648234 | PubTator, text mining | PubMed |
| A Minimal Model Framework for Robust CAR-T Cell and Oncolytic Virus Combination Therapy. | Res Sq | 2026 | 41646370 | PubTator, text mining | PubMed |
| Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptor. | Nat Commun | 2026 | 41639073 | PubTator, text mining | PubMed |
| Development of a quadruple-conjugated carbon dot nanomodel for targeted glioma therapy. | Commun Chem | 2026 | 41618001 | PubTator, text mining | PubMed |
| Dual targeting of CD155 augments the antitumor efficacy of ROR1-CAR-T cells in ovarian cancer. | Cancer Immunol Immunother | 2026 | 41591545 | PubTator, text mining | PubMed |
| Multimodal profiling of CAR T cells against glioblastoma using a microengineered 3D tumor-on-a-chip model. | Bioact Mater | 2026 | 41584077 | PubTator, text mining | PubMed |
| Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort Study. | Clin Transl Gastroenterol | 2026 | 41563717 | PubTator, text mining | PubMed |
| Structure-Guided Discovery of CHI3L1 Inhibitors from Ultralarge Chemical Spaces for Glioblastoma Therapy. | ACS Omega | 2026 | 41552549 | PubTator, text mining | PubMed |
| Engineered atopic dermatitis models for recreating hypoxic conditions in atopic dermatitis microenvironments. | Bioact Mater | 2026 | 41551767 | PubTator, text mining | PubMed |
| Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma. | Commun Biol | 2026 | 41540212 | PubTator, text mining | PubMed |
| Next-generation CAR-T therapy for acute myeloid leukemia: bridging innovation with clinical translation. | Ann Hematol | 2026 | 41537901 | PubTator, text mining | PubMed |
| Mathematical modeling of combinatorial antigen targeting with multiple CAR T-cell products for glioblastoma treatment. | NPJ Syst Biol Appl | 2026 | 41501087 | PubTator, text mining | PubMed |
| Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial. | Nat Commun | 2026 | 41495049 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=4